Ardelyx Inc

ARDXNASDAQ · USD
3.07USD0.00 (-0.65%)
442

Ardelyx Inc (ARDX) Historical Volatility

ARDX's 30 day historical volatility is 53.22%, in the 55th percentile of readings over the past year. This is an average percentile, meaning Ardelyx Inc shares have moved roughly in line with their typical range. ARDX's 30 day implied volatility sits at 308.55%, with an IV Rank of 97.22%, leaving IV 255.33 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 16, 2026.

Read more

Tracking ARDX historical volatility helps you see how much Ardelyx Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, ARDX's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor ARDX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. ARDX's 30 day historical volatility, or ARDX HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing ARDX's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.

Historical Volatility

HV Percentile
55thHV Percentile
Moderate

Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.

Historical Volatility (30d)53.22%

HV Percentile55th

Implied Volatility (30d)308.55%

IV Rank97.22%

IV Minus HV+255.33%

As of Nov 16, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 16, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →